← back to search

Daniela Huzly

German Medical Association · DE
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, Cytomegalovirus and herpesvirus research, and Viral Infections and Immunology Research.
h-index
30
citations
3,265
works
132
NIH funding
primary concept
Medicine
email

Recent publications

Revision of the “Guideline of the German Medical Association on Quality Assurance in Medical Laboratory Examinations – Rili-BAEK”
Journal of Laboratory Medicine 2024cited by 17position: middledoi
Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity
Journal of Translational Medicine 2022cited by 4position: middledoi
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May–August 2020
Emerging infectious diseases 2021cited by 32position: middledoi
A human adenovirus species B subtype 21a associated with severe pneumonia
Journal of Infection 2014cited by 44position: middledoi
Pharmacologically Triggered Hydrogel for Scheduling Hepatitis B Vaccine Administration
Scientific Reports 2013cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Katrin Schöneweis · Gilead Sciences (United States)1 papers (2013–2013)Albert Heim · Medizinische Hochschule Hannover1 papers (2014–2014) · 1 papers (2022–2022)Saskia Lehr · University of Fribourg1 papers (2022–2022) · 1 papers (2013–2013)Robert Thimme · Heinrich Heine University Düsseldorf1 papers (2022–2022)Frank Meiß · University of Fribourg1 papers (2022–2022)Tina Ganzenmueller · STZ eyetrial1 papers (2014–2014) · 1 papers (2013–2013) · 1 papers (2013–2013)Stephan Urban · University Hospital Münster1 papers (2013–2013)Zhen Zhang · University City Science Center1 papers (2022–2022)Robert Beck · University of Tübingen1 papers (2014–2014)David J. Pinato · Imperial College London1 papers (2022–2022)Elias Hage · Medizinische Hochschule Hannover1 papers (2014–2014)Nico Buettner · University of Birmingham1 papers (2022–2022)Marie Daoud‐El Baba · Université Claude Bernard Lyon 11 papers (2013–2013)David Rafei‐Shamsabadi · Novartis (Switzerland)1 papers (2022–2022)Thomas F. Schulz · Medizinische Hochschule Hannover1 papers (2014–2014)Ghislaine Charpin‐El Hamri · ETH Zurich1 papers (2013–2013)